Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 6, Pages e39741
Publisher
Public Library of Science (PLoS)
Online
2012-06-28
DOI
10.1371/journal.pone.0039741
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success
- (2012) Angela M. Mitchell et al. CURRENT GENE THERAPY
- Adeno-Associated Virus Antibody Profiles in Newborns, Children, and Adolescents
- (2011) Roberto Calcedo et al. Clinical and Vaccine Immunology
- The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
- (2011) F. Sonntag et al. JOURNAL OF VIROLOGY
- Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity
- (2011) Melissa Bartel Frontiers in Microbiology
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- A viral assembly factor promotes AAV2 capsid formation in the nucleolus
- (2010) F. Sonntag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
- (2010) Ivonne Rubio et al. VIROLOGY
- Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations
- (2009) Jorge Boucas et al. JOURNAL OF GENE MEDICINE
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
- (2009) Subhashini Jagu et al. JNCI-Journal of the National Cancer Institute
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure
- (2009) Valérie Guyard-Dangremont et al. PROTEIN SCIENCE
- Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
- (2009) Ivonne Rubio et al. VACCINE
- Role of Heparan Sulfate in Attachment to and Infection of the Murine Female Genital Tract by Human Papillomavirus
- (2008) K. M. Johnson et al. JOURNAL OF VIROLOGY
- Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus Capsids
- (2008) P. M. Day et al. JOURNAL OF VIROLOGY
- Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies
- (2008) P. M. Day et al. JOURNAL OF VIROLOGY
- Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2
- (2008) H. H. Alphs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now